Screener
PTC Therapeutics PTCT EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from PTC Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
FAQ
- What is PTC Therapeutics's EV / EBITDA?
- PTC Therapeutics (PTCT) reported EV / EBITDA of 86.6× in Q1 2026.
- How has PTC Therapeutics's EV / EBITDA changed year-over-year?
- PTC Therapeutics's EV / EBITDA increased by 2087.3% year-over-year, from 4× to 86.6×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about PTC Therapeutics's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude